|
Valoración de DCF de Zoetis Inc. (ZTS)
US | Healthcare | Drug Manufacturers - Specialty & Generic | NYSE
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Zoetis Inc. (ZTS) Bundle
Diseñada para la precisión, nuestra calculadora DCF de Zoetis Inc. (ZTS) le permite evaluar la valoración de Zoetis Inc. utilizando datos financieros del mundo real, ofreciendo una flexibilidad completa para modificar todos los parámetros clave para proyecciones mejoradas.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 6,260.0 | 6,675.0 | 7,776.0 | 8,080.0 | 8,544.0 | 9,244.1 | 10,001.5 | 10,821.1 | 11,707.7 | 12,667.1 |
Revenue Growth, % | 0 | 6.63 | 16.49 | 3.91 | 5.74 | 8.19 | 8.19 | 8.19 | 8.19 | 8.19 |
EBITDA | 2,455.0 | 2,686.0 | 3,172.0 | 3,358.0 | 3,685.0 | 3,788.9 | 4,099.4 | 4,435.3 | 4,798.7 | 5,191.9 |
EBITDA, % | 39.22 | 40.24 | 40.79 | 41.56 | 43.13 | 40.99 | 40.99 | 40.99 | 40.99 | 40.99 |
Depreciation | 412.0 | 441.0 | 448.0 | 465.0 | 491.0 | 563.0 | 609.1 | 659.0 | 713.0 | 771.5 |
Depreciation, % | 6.58 | 6.61 | 5.76 | 5.75 | 5.75 | 6.09 | 6.09 | 6.09 | 6.09 | 6.09 |
EBIT | 2,043.0 | 2,245.0 | 2,724.0 | 2,893.0 | 3,194.0 | 3,225.9 | 3,490.3 | 3,776.3 | 4,085.7 | 4,420.5 |
EBIT, % | 32.64 | 33.63 | 35.03 | 35.8 | 37.38 | 34.9 | 34.9 | 34.9 | 34.9 | 34.9 |
Total Cash | 1,932.0 | 3,602.0 | 3,482.0 | 3,577.0 | 2,041.0 | 3,656.3 | 3,955.8 | 4,280.0 | 4,630.7 | 5,010.1 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 1,086.0 | 1,013.0 | 1,133.0 | 1,215.0 | 1,304.0 | 1,430.9 | 1,548.1 | 1,675.0 | 1,812.2 | 1,960.7 |
Account Receivables, % | 17.35 | 15.18 | 14.57 | 15.04 | 15.26 | 15.48 | 15.48 | 15.48 | 15.48 | 15.48 |
Inventories | 1,410.0 | 1,628.0 | 1,923.0 | 2,345.0 | 2,564.0 | 2,415.9 | 2,613.9 | 2,828.1 | 3,059.8 | 3,310.5 |
Inventories, % | 22.52 | 24.39 | 24.73 | 29.02 | 30.01 | 26.14 | 26.14 | 26.14 | 26.14 | 26.14 |
Accounts Payable | 301.0 | 457.0 | 436.0 | 405.0 | 411.0 | 500.7 | 541.8 | 586.2 | 634.2 | 686.2 |
Accounts Payable, % | 4.81 | 6.85 | 5.61 | 5.01 | 4.81 | 5.42 | 5.42 | 5.42 | 5.42 | 5.42 |
Capital Expenditure | -460.0 | -453.0 | -477.0 | -586.0 | -732.0 | -667.2 | -721.9 | -781.0 | -845.0 | -914.3 |
Capital Expenditure, % | -7.35 | -6.79 | -6.13 | -7.25 | -8.57 | -7.22 | -7.22 | -7.22 | -7.22 | -7.22 |
Tax Rate, % | 20.16 | 20.16 | 20.16 | 20.16 | 20.16 | 20.16 | 20.16 | 20.16 | 20.16 | 20.16 |
EBITAT | 1,701.6 | 1,842.3 | 2,230.2 | 2,302.6 | 2,550.0 | 2,623.7 | 2,838.7 | 3,071.3 | 3,322.9 | 3,595.2 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -541.4 | 1,841.3 | 1,765.2 | 1,646.6 | 2,007.0 | 2,630.4 | 2,451.7 | 2,652.6 | 2,870.0 | 3,105.1 |
WACC, % | 8.27 | 8.27 | 8.27 | 8.26 | 8.26 | 8.27 | 8.27 | 8.27 | 8.27 | 8.27 |
PV UFCF | ||||||||||
SUM PV UFCF | 10,787.6 | |||||||||
Long Term Growth Rate, % | 4.00 | |||||||||
Free cash flow (T + 1) | 3,229 | |||||||||
Terminal Value | 75,690 | |||||||||
Present Terminal Value | 50,882 | |||||||||
Enterprise Value | 61,670 | |||||||||
Net Debt | 4,716 | |||||||||
Equity Value | 56,954 | |||||||||
Diluted Shares Outstanding, MM | 462 | |||||||||
Equity Value Per Share | 123.21 |
What You Will Get
- Real ZTS Financials: Access to both historical and forecasted data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
- Scenario Analysis: Explore various scenarios to assess Zoetis' future performance.
- User-Friendly Design: Designed for professionals while remaining approachable for newcomers.
Key Features
- Comprehensive Historical Data: Zoetis Inc.'s financial statements and pre-filled projections.
- Customizable Parameters: Adjust WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Real-Time Valuation: Instantly view Zoetis Inc.'s intrinsic value updates.
- Intuitive Visualizations: Dashboard graphs illustrate valuation outcomes and essential metrics.
- Designed for Precision: A reliable resource for analysts, investors, and finance professionals.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered Zoetis Inc. (ZTS) data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for Zoetis Inc. (ZTS) intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose This Calculator for Zoetis Inc. (ZTS)?
- Accuracy: Utilizes real Zoetis financial data for precise calculations.
- Flexibility: Allows users to easily test and adjust inputs as needed.
- Time-Saving: Avoid the complexities of creating a DCF model from the ground up.
- Professional-Grade: Crafted with the expertise and precision expected at the CFO level.
- User-Friendly: Intuitive interface designed for users of all financial backgrounds.
Who Should Use This Product?
- Investors: Assess Zoetis Inc.'s (ZTS) valuation before making stock transactions.
- CFOs and Financial Analysts: Enhance valuation workflows and evaluate financial forecasts.
- Startup Founders: Discover how leading public companies like Zoetis Inc. (ZTS) are appraised.
- Consultants: Provide comprehensive valuation reports for your clientele.
- Students and Educators: Utilize real-time data to practice and instruct on valuation strategies.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Zoetis Inc. (ZTS) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Zoetis Inc. (ZTS).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.